Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Future Program: Laguna

Open

DARPA-SN-27-15Federal

Response Deadline11/30/2026, 07:00:00 AM EST

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Special Notice DARPA-SN-27-15, issued by the Defense Advanced Research Projects Agency Biological Technologies Office, serves as a public notification for the forthcoming Laguna program. This notice is intended for information and program planning purposes and does not constitute a formal solicitation for proposals. The program is anticipated to be a 36-month effort focused on the development and demonstration of defense-relevant specialty products formulated from U.S.-produced raw materials. These products must meet or exceed the critical performance requirements of existing military materials. Key deliverables for the program include predictive tools for material properties, life cycle assessments, technoeconomic analyses, and commercialization strategy plans. The primary point of contact for the initiative is Dr. William Mounfield. While this notice provides an overview of research interests, DARPA will not accept submissions at this time. Formal solicitation details and submission instructions will be posted on sam.gov upon release. All communications regarding this notice must remain unclassified.

General Info

DARPA notice for the Laguna program developing defense-relevant products from U.S. materials.

Agency

Department Of Defense → Defense Advanced Research Projects Agcy

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

VA

Set-Aside

NONE

Documents

1

special-notice

Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PostedNov 5

special-notice

Response DeadlineNov 30

Submission deadline

Response Deadline

11/30/2026, 07:00:00 AM ESTin 25 days

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy

Contacts1 person available

OfficeARLINGTON, VA, 222032114, USA

Organization / AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy

Office AddressARLINGTON, VA, 222032114, USA

Contacts

Dr. William Mounfield DARPA/BTO

contact@example.gov

Full Description

Show more

The purpose of this Special Notice (SN) is to provide public notification of additional research areas of interest to the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO), specifically for the forthcoming Laguna program. When released, the solicitation will be made available at https://sam.gov/. Additionally, this SN may be amended with a draft solicitation when available.

Similar Contracts

Same NAICS industry code

Immunohistochemical (IHC) Analysis SupportThe Immunohistochemical (IHC) Analysis Support subcontract, issued by the NASA Shared Services Center, involves providing specialized staining and chemical analysis of sectioned tissue for prime contractors on NASA Space Biosciences projects. The scope of work requires the application of antibodies and reagents to cryo-sectioned slides and the use of fluorescence microscopes and IHC staining stations to evaluate neuronal morphology. Due to the technical nature of the work, specialized training in neuro-histology is required to deliver the final analyzed slides and digital imaging reports. This opportunity is categorized under NAICS code 541714 and is associated with a performance location in zip code 94035. The solicitation was posted on November 4, 2026, with a response deadline of November 9, 2026.

NASA Shared Services Center

POSTED

DEADLINE

Service request for specimen embedding and sectioning.

Solicitation # 80NSSC27948767Q

The NASA Shared Services Center is seeking custom histology research services to support a Space Biosciences Project evaluating neuronal morphology in mouse brains exposed to radiation, isolation, and simulated microgravity. The scope of work involves planning, preliminary testing, embedding, and cryo-sectioning of specific brain regions, including the substantia nigra, hippocampus, and prefrontal cortex. The contractor must provide slides with sections 15 microns thick, which are to be delivered to Principal Investigator Dr. Joshua Alwood within 90 days after receipt of order. Performance will be located at the NASA Ames Research Center. This procurement is being conducted under FAR Part 12 for commercial items and services, with the government intending to issue a sole source contract to ZYAGEN, identified as the sole provider of the required services. While the agency is currently requesting capability statements from interested organizations by November 9, 2026, to determine if a competitive procurement is feasible, it explicitly states that quotes will not be reviewed or accepted at this stage. Primary coordination for this effort is managed by Cara Craft and Will Garrett.

NASA Shared Services Center

POSTED

DEADLINE

Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)

Solicitation # RFA-AI-28-014

The National Institutes of Health (NIH) issued solicitation RFA-AI-28-014 to establish centers focused on the systems-level understanding of the links between infectious pathogens, inflammatory pathways, and chronic diseases. The program supports two types of centers: Chronic and Infectious Diseases Systems Biology Centers (CIDSB), which examine the bidirectional link between chronic and infectious diseases, and Systems Biology Inflammation Centers (SBI), which focus on the role of inflammation in chronic diseases to identify precision medicine targets. The primary goals are to develop predictive computational models for disease progression, discover novel drug targets and biomarkers, and create harmonized, FAIR-compliant cross-disease datasets. The total program funding is 26 million dollars, with an expected 10 awards and an individual award ceiling of 2.5 million dollars. Applications must be submitted electronically via Grants.gov by February 18, 2027. The proposal structure is multi-component, requiring an overall section, an administrative core, a data and modeling core, and a biospecimen collection and processing core, with additional requirements for research projects and optional cores depending on the center type. Evaluation is based on an overall impact score focusing on significance and the qualifications of the investigators. Awardees must comply with strict cybersecurity incident reporting requirements, notifying the HHS awarding agency within 48 hours of discovery, and must adhere to rigorous biosafety and human subjects protection standards. Applicants must maintain active SAM registration and UEI identifiers to be eligible for funding.

National Institutes Of Health

POSTED

DEADLINE

In Vivo Efficacy and Toxicology StudiesThis subcontract, titled In Vivo Efficacy and Toxicology Studies, supports the National Institutes of Health and the Department of Health and Human Services by providing preclinical validation of biologic therapies for prime contractors on NIH/NINDS ADRD projects. The scope of work involves executing in vivo efficacy, safety pharmacology, and toxicology studies utilizing translationally appropriate animal models specifically for Alzheimer's and Frontotemporal Dementia. To fulfill the requirements, the contractor must utilize GLP-compliant toxicology lab facilities to ensure regulatory standards are met. The primary deliverables include comprehensive preclinical validation reports and detailed toxicology data packages necessary for Investigational New Drug submission. The project is categorized under NAICS code 541714, with a response deadline set for October 10, 2028.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

Genome Editing Construct and Delivery System OptimizationThis subcontract focuses on the design and optimization of genome editing constructs and biologic delivery systems to support prime contractors on NIH/NINDS genomic therapy projects. The scope of work involves utilizing CRISPR/Cas technology along with viral and non-viral vectors to refine editing constructs and delivery mechanisms. The selected provider will be responsible for assessing critical metrics including bioactivity, target engagement, durability, pharmacokinetics, and bioavailability. The final deliverables for this engagement consist of optimized therapeutic leads accompanied by comprehensive bioactivity and pharmacokinetics data reports.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

NCI Research Specialist (Clinician Scientist)The NCI Research Specialist subcontract involves providing leadership and implementation services for National Cancer Institute funded clinical trials on behalf of prime contractors. The selected clinician scientist will be responsible for writing and revising protocols for national cancer clinical trials, managing trials within a clinical trials office, and recruiting patients. Additionally, the role requires active participation in NCI scientific review, monitoring, and steering committees. Candidates must possess clinician scientist status and demonstrated experience in cancer clinical research. The contract requires a dedicated effort ranging from 2.4 to 4.8 person-months per year. This opportunity is associated with the National Institutes of Health under the Department of Health and Human Services, with a response deadline set for February 20, 2029.

National Institutes Of Health

POSTED

DEADLINE

in over 2 years

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Solicitation # RFA-NS-28-012

The National Institutes of Health, under the Department of Health and Human Services, has issued solicitation RFA-NS-28-012 to support the translation of genome editing and biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). This includes Frontotemporal Dementia, Lewy Body Dementias, Vascular Contributions to Cognitive Impairment and Dementia, and Multiple Etiology Dementias. The program funds the entire translational pipeline, from therapeutic lead optimization and drug product development to IND-enabling studies and early first-in-human clinical evaluations. Key activities include optimizing editing constructs and delivery systems, demonstrating in vivo efficacy, conducting safety pharmacology and toxicology studies, and developing scalable manufacturing processes that align with regulatory expectations. The agency intends to commit 6 million dollars in both fiscal years 2028 and 2029, with an expected three awards and a maximum project period of five years. Individual annual budget caps are set at 1.3 million dollars in direct costs, increasing to 2.5 million dollars for projects involving clinical trials. Awards are governed by the Public Health Service Act and federal regulations 42 CFR Part 52 and 2 CFR Part 200. Evaluation is based on an Overall Impact Score considering significance, innovation, approach, investigator expertise, and environment, with a specific focus on the Target Product Profile and the use of quantitative Go/No-Go milestones. Eligible applicants include small businesses and other for-profit organizations. Requirements for submission include active registration in the System for Award Management, a Unique Entity Identifier, and eRA Commons accounts. Awardees must adhere to strict cybersecurity incident reporting protocols, notifying the agency within 48 hours of discovery, and must register applicable clinical trials with ClinicalTrials.gov. The solicitation features multiple application cycles with deadlines extending through October 10, 2028, and earliest start dates ranging from December 2027 to July 2029.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Solicitation # PAR-28-042

Solicitation PAR-28-042, issued by the National Institutes of Health under the Department of Health and Human Services, is a funding opportunity designed to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer. The program focuses on tools for cancer detection, diagnosis, prognosis, monitoring, and the prediction of treatment response or toxicity. Funding is available through either a phased UH2/UH3 mechanism or a standalone UH3 mechanism to facilitate laboratory optimization and clinical validation using human samples. Key deliverables include the demonstration of assay results associated with clinical endpoints, the establishment of statistical cut-off values, and the definition of sensitivity and specificity. All clinical laboratories must adhere to CLIA, GLP, or ISO 17025 standards. Awards are determined via a peer review system based on an overall impact score, evaluating the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Specific evaluation criteria include the clarity of milestones for transitioning from UH2 to UH3 phases and the adequacy of commercialization plans. Eligible applicants include small businesses, for-profit organizations, higher education institutions, and 501(c)(3) nonprofits. Applicants must maintain active registrations in SAM.gov, eRA Commons, and Grants.gov. Additionally, recipients must comply with strict cybersecurity incident reporting requirements, notifying the agency within 48 hours of discovery, and ensure all human subject protocols are reviewed by an Institutional Review Board or Independent Ethics Committee.

National Institutes Of Health

POSTED

DEADLINE

in about 3 years

Specialized Bioscience Research & AnalysisThe Specialized Bioscience Research and Analysis subcontract, issued by the Biotechnology and Biological Sciences Research Council under UK Research and Innovation, focuses on advancing the understanding of living systems through curiosity-driven research. The selected provider will support prime contractors on bioscience discovery projects by performing advanced biological research, laboratory analysis, and experimental validation. Key technical requirements include the use of high-throughput sequencing and advanced microscopy, with a final delivery expectation of comprehensive experimental data and peer-reviewed publications. To qualify for this engagement, providers must possess PhD or Post-doc credentials and maintain valid institutional biosafety certifications. The project emphasizes team science methodologies to achieve its research goals. Interested parties must submit their responses by February 9, 2027, in accordance with the solicitation posted on November 3, 2026.

Biotechnology and Biological Sciences Research Council (BBSRC)

POSTED

DEADLINE

2026 to 2027 strategic Longer and Larger (sLoLa): full stage

Solicitation # 189488

The Biotechnology and Biological Sciences Research Council (BBSRC), under UK Research and Innovation (UKRI), is soliciting proposals for the 2026 to 2027 Strategic Longer and Larger (sLoLa) program. This initiative funds large-scale, team-based, curiosity-driven bioscience discovery research projects aimed at achieving major breakthroughs in the fundamental understanding of living systems. Eligible projects must utilize a fully integrated team science approach, demonstrate a need for extended and large-scale funding, and enhance the overall capability and capacity of UK biosciences. Projects can last up to five years, and the full economic cost must exceed 2 million pounds, with BBSRC providing 80 percent of that cost. The selection process is conducted in two stages. The outline stage opened on April 16, 2026, and closed on June 25, 2026, with evaluations based on vision, approach, and team capability. Successful outline applicants are invited to the full stage, which opened on November 5, 2026, and closed on February 9, 2027. Full proposals are evaluated via external peer review and a multidisciplinary panel, focusing on management strategy and strategic case. Final funding recommendations are made by the Strategic LoLa Committee following an interview process with the highest-rated teams. All applications are managed through the UKRI Funding Service.

Biotechnology and Biological Sciences Research Council (BBSRC)

POSTED

DEADLINE

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Solicitation # PAR-28-042

The National Cancer Institute, under the National Institutes of Health, has issued solicitation PAR-28-042 to provide funding for the analytical and clinical validation of biomarkers and assays related to cancer. This initiative focuses on molecular, cellular, and imaging markers used for detection, diagnosis, prognosis, treatment response, prevention, and toxicity monitoring. The goal is to support laboratory optimization and validation for assays using human samples that address specific clinical needs and intended uses. Eligible projects may utilize either a standalone UH3 mechanism or a phased UH2/UH3 approach, though clinical trials are explicitly not allowed. The solicitation was posted on November 3, 2026, with a response deadline set for November 17, 2029.

National Cancer Institute

POSTED

DEADLINE

in about 3 years

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Solicitation # RFA-NS-28-012

The National Institute of Neurological Disorders and Stroke, under the National Institutes of Health, has issued solicitation RFA-NS-28-012 to support the translation of genome editing and biologic therapies for Alzheimer's Disease-Related Dementias. This initiative covers a broad range of conditions, including Frontotemporal Dementia, Lewy Body Dementias, Vascular Contributions to Cognitive Impairment and Dementia, and Multiple Etiology Dementias. The program is designed to advance the translational pipeline from initial therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation. Eligible activities include the optimization of delivery systems and editing constructs, the assessment of bioactivity and pharmacokinetics, and the demonstration of in vivo efficacy. Additionally, the funding supports safety pharmacology, toxicology studies, and the creation of scalable manufacturing processes and quality attributes that meet regulatory standards. This solicitation was posted on November 3, 2026, with a response deadline of October 11, 2028.

National Institute Of Neurological Disorders And Stroke

POSTED

DEADLINE

in almost 2 years

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

Predictive Tool Development for Material PropertiesThis subcontract opportunity involves the development of computational tools designed to predict material properties in support of prime contractors working on DARPA Biological Technologies Office projects. The primary objective is to create predictive models and software tools that can forecast material formulation behavior by leveraging high-performance computing, molecular modeling software, and artificial intelligence or machine learning frameworks. Managed under the Department of Defense for the Defense Advanced Research Projects Agency, the project falls under NAICS code 541715. The successful provider will be responsible for the delivery of functional predictive software tools that accurately determine material properties. Interested parties should note the response deadline of November 30, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 4 hours ago

DEADLINE

Technoeconomic Analysis (TEA) and Life Cycle Assessment (LCA) ServicesThis subcontract involves providing specialized economic and environmental impact analyses for prime contractors working on projects for the DARPA Biological Technologies Office. The scope of work focuses on conducting Technoeconomic Analysis to determine cost-viability and performing Life Cycle Assessments in accordance with ISO 14040 and 14044 standards. These assessments must be executed using industry-standard software such as SimaPro or GaBi. In addition to technical analyses, the contractor is responsible for developing comprehensive commercialization strategy plans. The primary deliverables for this engagement include detailed TEA reports, LCA reports, and strategic commercialization frameworks. This effort falls under NAICS code 541620 and supports the Department of Defense.

Environmental Consulting Services

POSTED

about 4 hours ago

DEADLINE

Specialty Product Formulation and DemonstrationThis subcontract, titled Specialty Product Formulation and Demonstration, is issued by the Defense Advanced Research Projects Agency under the Department of Defense. The project focuses on the development and demonstration of fully formulated, defense-relevant specialty products intended for prime contractors working on Biological Technologies Office projects. A primary requirement of the contract is the use of U.S.-produced raw materials to ensure that the resulting products meet or exceed the performance standards of current military materials. The scope of work involves utilizing specialized chemical formulation, material synthesis, and performance testing facilities to deliver final products and successful performance demonstrations. Interested parties should note that the solicitation was posted on November 5, 2026, with a response deadline of November 30, 2026. The effort is categorized under NAICS code 325998.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

Compliant Robotic Structures EngineeringThis subcontract for Compliant Robotic Structures Engineering supports prime contractors on DARPA projects within the Department of Defense. The scope of work involves the design and integration of flexoelectric and strain-gradient materials into robotic frames or skins to facilitate adaptive movement and proprioception. Utilizing additive manufacturing and robotics prototyping labs, the contractor is responsible for delivering integrated structural components or fully compliant robotic prototypes. The opportunity was posted on November 4, 2026, with a response deadline of December 4, 2026. It is categorized under NAICS code 333996, focusing on specialized engineering and manufacturing for advanced robotic applications.

Fluid Power Pump and Motor Manufacturing

POSTED

DEADLINE

Morphological & Physical Compute System DevelopmentThis subcontract, titled Morphological and Physical Compute System Development, involves the creation of physical-compute device elements and morphological-compute systems to support prime contractors on projects for the Defense Advanced Research Projects Agency. The scope of work focuses on designing physical-compute elements that utilize the mechanical state of materials to perform computational functions, leveraging specialized fabrication techniques and advanced computing architecture tools. The primary deliverables for this engagement include functional physical-compute prototypes and detailed architectural models. This opportunity is categorized under NAICS code 541715 and was posted on November 4, 2026, with a response deadline of December 4, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Adaptive Transduction & Sensing Device DesignThis subcontract, titled Adaptive Transduction & Sensing Device Design, supports prime contractors on projects for the Defense Advanced Research Projects Agency within the Department of Defense. The scope of work involves the design and prototyping of device elements for distributed sensing and adaptive transduction, specifically utilizing flexoelectric principles. The contractor is responsible for developing elements that encode mechanical states and creating adaptive transduction systems through the use of CAD software and MEMS fabrication facilities. Key deliverables for this engagement include functional performance reports, detailed design schematics, and physical device prototypes. The project falls under NAICS code 541330, with a response deadline set for December 4, 2026.

Engineering Services

POSTED

DEADLINE

Precision Metrology & Characterization ServicesThis subcontract for Precision Metrology and Characterization Services supports DARPA projects by providing high-precision measurement and validation of the electromechanical response of flexoelectric materials. The scope of work involves utilizing nano-metrology equipment and high-precision sensors to measure local mechanical states and validate strain-gradient effects for prime contractors. The selected provider must hold ISO/IEC 17025 certification to ensure technical competence and accuracy. Key deliverables include comprehensive metrology data sets, detailed validation reports, and formal measurement accuracy certifications. The opportunity was posted on November 4, 2026, with a response deadline of December 4, 2026, under NAICS code 541715.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Flexoelectric Materials Research & DevelopmentThe Flexoelectric Materials Research and Development subcontract, issued under the Defense Advanced Research Projects Agency within the Department of Defense, focuses on the foundational research of materials using strain-gradient-driven electromechanical responses. The project aims to explore materials and interfaces capable of discriminating or encoding local mechanical states, utilizing atomic force microscopy and advanced synthesis laboratories to achieve these goals. The successful contractor will be responsible for delivering validated design rules, detailed characterization reports, and physical material samples. This effort supports prime contractors on DARPA projects under NAICS code 541715, with a response deadline set for December 4, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Request for Information: Flexoelectric Future

Solicitation # DARPA-SN-27-10

The Defense Advanced Research Projects Agency DARPA Multi X Office MXO issued a Request for Information RFI under solicitation number DARPA-SN-27-10 to gather data on flexoelectric materials. This effort aims to inform future research on sensing and transduction technologies that operate under strict size, weight, power, communications, and environmental constraints. The scope focuses on foundational materials, interfaces, metrology, design rules, and device elements capable of using strain-gradient-driven electromechanical responses to encode or discriminate local mechanical states. This research is intended to support future developments in distributed sensing, adaptive transduction, morphological-compute systems, and compliant robotic structures. The RFI seeks innovative insights across three technical areas: state-of-the-art materials and scale-up pathways, state-selective strain-gradient transduction device elements for distinguishing conditions like impact or fatigue, and exploratory approaches to make strain-gradient transduction a viable technology platform. Responses must be submitted by December 4, 2026, via email to [email hidden]. Submissions must follow strict formatting guidelines, including 11-point font and specific page limits for each technical area, with a maximum of ten technical pages total. As this is an RFI for program planning purposes, it does not constitute a formal solicitation for proposals, and responses are not offers for a binding contract.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Classified Information Management & Marking ServicesThe Classified Information Management and Marking Services subcontract supports prime contractors on DARPA FLASH projects by providing specialized expertise in the marking, handling, and transmission of classified national security information. The scope of work involves delivering marked and transmitted classified technical reports while ensuring strict adherence to EO 13526, DoDM 5200.01, DoDM 5105.21 for SCI, and DoDM 5205.07 for SAP. All operations must be conducted within secure facilities using encrypted hardware. To qualify for this engagement, personnel must possess a Top Secret/SCI clearance and hold FSO certification. This opportunity is categorized under NAICS code 541690 and is associated with the Defense Advanced Research Projects Agency under the Department of Defense. Interested parties must respond by November 30, 2026.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Heterogeneous System Architecture DesignThe Heterogeneous System Architecture Design subcontract, issued by the Defense Advanced Research Projects Agency under the Department of Defense, focuses on creating technical frameworks and architectures for DARPA FLASH projects. The primary objective is to enable semantic heterogeneity within cyber-physical systems by decoupling high-level requirements from instance-level design. Additionally, the project involves developing specific metrics to vary attack surfaces and failure modes to enhance system resilience. Qualified contractors must possess either a Secret or Top Secret security clearance and maintain strict compliance with NISPOM standards. The expected deliverables for this engagement include comprehensive architecture descriptions, technical frameworks, and detailed evaluation criteria. The solicitation was posted on November 3, 2026, with a response deadline of November 30, 2026, falling under NAICS code 541330.

Engineering Services

POSTED

DEADLINE

Formal Specifications and Proofs DevelopmentThis subcontract for the Defense Advanced Research Projects Agency involves the development of formalized specifications, models, and mathematical proofs to support prime contractors on DARPA FLASH cyber-physical engineering projects. The scope of work focuses on applying formal verification methods through tools such as Coq, Isabelle, or TLA+ to ensure functional equivalence across heterogeneous systems, resulting in the delivery of reusable libraries of specifications and proofs. The opportunity is categorized under NAICS code 541715 and requires personnel to hold either a Secret or Top Secret security clearance. Interested parties must respond by November 30, 2026, regarding this Department of Defense initiative.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS